Haleon HLN
NYSE HLN
$9.91 +0.05 (+0.46%)
At close: Aug 20, 2026 · 12:00 PM UTC

Haleon (HLN) Capital Expenditures Growth (1y) (2022 - 2023)

Haleon (HLN) Capital Expenditures Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Haleon 44.05 Bn 43.08 Bn - -
2 Teva Pharmaceutical Industries 43.39 Bn 39.74 Bn 2.15 Bn 8.33%
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn -19.86%
4 Takeda Pharmaceutical 28.78 Bn 22.99 Bn 5.10 Bn -1.95%
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 73.63%
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -0.19%
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn -37.60%
8 Elanco Animal Health 11.92 Bn 11.39 Bn 798.00 Mn -42.11%
9 Dr Reddys Laboratories 10.16 Bn 9.99 Bn - -
10 Alkermes 8.17 Bn 7.51 Bn 397.90 Mn -37.42%

Historic Data

Download Data
DateValue
Dec 31, 2023 -65.51%
Dec 31, 2022 23.74%